Effects of Nutritional Counseling Regularity on the Risk of Cardiovascular Diseases

October 11, 2021 updated by: Taipei Medical University
This study aims to investigate the frequency of personalized nutrition counseling's effect on individual cardiovascular risk factors. The study collected 110 to 150 cases data, including a regular blood test, blood glucose, blood lipid, liver panel, and inflammatory factors. The enrolled cases were classified into two groups according to the subjects' duration of consultation: those who completed the consultation and subsequent tests in >24 weeks were in the control group, whereas those who completed the consultation and subsequent tests in <24 weeks were in the test group. The effectiveness of nutrition consultation toward managing cardiovascular disease risk factors and its correlation with the subjects' frequency of following the consultations was analyzed using the pre- and post-consultation data. It was found that personalized nutrition consultation significantly improved the subjects' risk factors of cardiovascular diseases, and that the treatment group showed a greater improvement than the control group which who require over 24 weeks to complete all consultation sessions.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The most of interventional studies on nutrition consultation have generally emphasized on the extent to which the diet composition can prevent chronic diseases or provide improvement. Although dietitians play an important role in health education for the primary prevention of chronic disease, their individuals dietary consultation results are mostly focused on weight loss and blood glucose control. However, the effectiveness of nutrition consultation on the prevention of chronic diseases, such as hyperlipidemia, hypertension and cardiovascular diseases, has few been studied. The effectiveness of dietary instructions provided to individuals by dietitians in primary health care institutes is yet to be validated with significant evidence. In addition, nutrition consultation methods, processes, and influencing factors on its results are seldom discussed. Therefore, this study aims to investigate the frequency of personalized nutrition counseling's effect on individual cardiovascular risk factors. The study collected1 10 to 150 cases data who aimed to prevent or improve chronic diseases and had completed eight times individualized nutrition consultations from Bon Vivant Health Lifestyle Management Center, and the pre- and post-consultation data, including a regular blood test, blood glucose, blood lipid, liver panel, and inflammatory factors, will be analyzed. Blood were drawn before and after the first and the last time consultation for biochemical tests; blood pressure and body composition was also measured for comparison. The enrolled cases will be classified into two groups according to the subjects' duration of consultation: those who completed the consultation and subsequent tests in >24 weeks were in the control group, whereas those who completed the consultation and subsequent tests in <24 weeks were in the test group. The effectiveness of nutrition consultation toward managing cardiovascular disease risk factors and its correlation with the subjects' frequency of following the consultations was analyzed using the pre- and post-consultation data. It was found that personalized nutrition consultation significantly improved the subjects' risk factors of cardiovascular diseases, and that the treatment group showed a greater improvement than the control group which who require over 24 weeks to complete all consultation sessions.

Study Type

Observational

Enrollment (Actual)

129

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 110
        • Taipei Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

People who volunteer to pay and completed nutrition consultations from Bon-Vivant Health Lifestyle Management Center.

Description

Inclusion Criteria:

  • Age ≧ 20
  • Anyone of follow: body mass index > 24 systolic blood pressure > 120 mmHg diastolic blood pressure > 80 mmHg triglyceride > 150 mg/dL fasting blood glucose >100 mg/dL

Exclusion Criteria:

  • Age <20
  • pregnant
  • Mental problem
  • unable to do the measurement of body composition
  • incomplete the nutritional counseling program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control group/ non-regularity group
those who completed 8 consultations by average interval time more than 3 weeks were in the non-regularity group
nutrition counseling
test group/ regularity group
those who completed the consultations and interval time within in 3 weeks were in the higher regularity
nutrition counseling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
body weight
Time Frame: baseline, pre-intervention
body weight in kilograms
baseline, pre-intervention
body weight
Time Frame: immediately after the intervention
body weight in kilograms
immediately after the intervention
height
Time Frame: baseline, pre-intervention
height in meters
baseline, pre-intervention
height
Time Frame: immediately after the intervention
height in meters
immediately after the intervention
body mass index
Time Frame: baseline, pre-intervention
body mass index in kg/m^2
baseline, pre-intervention
body mass index
Time Frame: immediately after the intervention
body mass index in kg/m^2
immediately after the intervention
body fat
Time Frame: baseline, pre-intervention
body fat in ratio
baseline, pre-intervention
body fat
Time Frame: immediately after the intervention
body fat in ratio
immediately after the intervention
The concentration of blood triglyceride
Time Frame: baseline, pre-intervention
blood triglyceride in mg/dL
baseline, pre-intervention
The concentration of blood total cholesterol
Time Frame: within one week after the intervention
blood total cholesterol in mg/dL
within one week after the intervention
The concentration of blood low density lipoprotein-cholesterol
Time Frame: baseline, pre-intervention
blood blood low density lipoprotein-cholesterol in mg/dL
baseline, pre-intervention
The concentration of blood low density lipoprotein-cholesterol
Time Frame: within one week after the intervention
blood blood low density lipoprotein-cholesterol in mg/dL
within one week after the intervention
The concentration of blood high density lipoprotein-cholesterol-cholesterol
Time Frame: baseline, pre-intervention
blood high density lipoprotein-cholesterol in mg/dL
baseline, pre-intervention
The concentration of blood high density lipoprotein-cholesterol-cholesterol
Time Frame: within one week after the intervention
blood high density lipoprotein-cholesterol in mg/dL
within one week after the intervention
The concentration of blood high sensitive C-reactive protein
Time Frame: baseline, pre-intervention
blood high sensitive sensitive C-reactive protein in mg/L
baseline, pre-intervention
The concentration of blood high sensitive C-reactive protein
Time Frame: within one week after the intervention
blood high sensitive sensitive C-reactive protein in mg/L
within one week after the intervention
The concentration of blood fasting glucose
Time Frame: baseline, pre-intervention
blood fasting glucose in mg/dL
baseline, pre-intervention
The concentration of blood fasting glucose
Time Frame: within one week after the intervention
blood fasting glucose in mg/dL
within one week after the intervention
blood HbA1C
Time Frame: baseline, pre-intervention
blood HbA1C in percentage
baseline, pre-intervention
blood HbA1C
Time Frame: within one week after the intervention
blood HbA1C in percentage
within one week after the intervention
The concentration of blood insulin
Time Frame: baseline, pre-intervention
blood insulin in mg/dL
baseline, pre-intervention
The concentration of blood insulin
Time Frame: within one week after the intervention
blood insulin in mg/dL
within one week after the intervention
The activity of blood aspartate aminotransferase
Time Frame: baseline, pre-intervention
blood aspartate aminotransferase in U/L
baseline, pre-intervention
The activity of blood aspartate aminotransferase
Time Frame: within one week after the intervention
blood aspartate aminotransferase in U/L
within one week after the intervention
The activity of blood alanine aminotransferase
Time Frame: baseline, pre-intervention
blood alanine aminotransferase in U/L
baseline, pre-intervention
The activity of blood alanine aminotransferase
Time Frame: within one week after the intervention
blood alanine aminotransferase in U/L
within one week after the intervention
The concentration of blood urinary nitrogen (BUN)
Time Frame: baseline, pre-intervention
BUN in mg/L
baseline, pre-intervention
The concentration of blood urinary nitrogen (BUN)
Time Frame: within one week after the intervention
BUN in mg/L
within one week after the intervention
The concentration of blood creatinine
Time Frame: baseline, pre-intervention
BUN in mg/dL
baseline, pre-intervention
The concentration of blood creatinine
Time Frame: within one week after the intervention
BUN in mg/dL
within one week after the intervention
The concentration of blood uric acid
Time Frame: baseline, pre-intervention
blood uric acid in mg/dL
baseline, pre-intervention
The concentration of blood uric acid
Time Frame: within one week after the intervention
blood uric acid in mg/dL
within one week after the intervention
The concentration of blood total protein
Time Frame: baseline, pre-intervention
blood uric acid in mg/dL
baseline, pre-intervention
The concentration of blood total protein
Time Frame: within one week after the intervention
blood uric acid in mg/dL
within one week after the intervention
The concentration of blood albumin
Time Frame: baseline, pre-intervention
blood uric acid in mg/dL
baseline, pre-intervention
The concentration of blood albumin
Time Frame: within one week after the intervention
blood uric acid in mg/dL
within one week after the intervention
The concentration of blood globulin
Time Frame: baseline, pre-intervention
blood uric acid in mg/dL
baseline, pre-intervention
The concentration of blood globulin
Time Frame: within one week after the intervention
blood uric acid in mg/dL
within one week after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Suh-Ching Yang, Taipei Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 21, 2021

Primary Completion (ACTUAL)

May 31, 2021

Study Completion (ACTUAL)

May 31, 2021

Study Registration Dates

First Submitted

September 1, 2021

First Submitted That Met QC Criteria

October 11, 2021

First Posted (ACTUAL)

October 25, 2021

Study Record Updates

Last Update Posted (ACTUAL)

October 25, 2021

Last Update Submitted That Met QC Criteria

October 11, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebrovascular Disease

Clinical Trials on nutrition counseling

3
Subscribe